South Africa to Manufacture Twice-Yearly HIV Prevention Drug

    A South African laboratory is set to produce a generic version of lenacapavir, a revolutionary twice-yearly HIV injection, marking a significant milestone in Africa’s push toward pharmaceutical self-sufficiency, global health agency Unitaid announced on Tuesday. Lenacapavir, originally developed by American pharmaceutical giant Gilead Sciences, has drawn widespread medical attention for its exceptional efficacy….

Read Full News
FG Mandates Drug Tests for Students

FG Mandates Drug Tests for Students

The Federal Government has ordered mandatory drug integrity tests for all secondary school students entering the Nigerian education system. Under the newly released National Implementation Guidelines, schools must screen every new arrival before they can take their seats in the classroom. This is not a one-off hurdle for freshers. The policy directs school administrators to…

Read Full News